CNC

Centene Corp presents a distinctive profile among managed care peers, trading at a Price-to-Sales ratio of 0.15 despite recording 17.02% revenue growth year-over-year. This compression reflects the company's current profitability challenges, with a negative ROE of -28.72% and operating margin of -3.68%, marking a stark contrast to the typically profitable managed care sector. The current price of $58.23 positions the stock near the upper end of its 52-week range ($25.08–$62.21), yet the market capitalization of $28.8 billion remains substantially below sector leader UNH.

Systematic screening highlights several operational factors:

• Revenue momentum demonstrates resilience with double-digit top-line expansion of 17.02%, indicating continued membership growth and market share gains in government-sponsored programs
• The Price-to-Book ratio of 1.01 trades near tangible book value of $40.57 per share, potentially reflecting limited premium for intangible franchise value
• Balance sheet positioning shows a Debt-to-Equity ratio of 0.87 with a Current ratio of 1.1, maintaining adequate liquidity despite operational headwinds
• Beta of 1.07 suggests modest correlation with broader market movements, consistent with healthcare services exposure

The primary risk factor centers on profitability metrics, with negative net margin of -3.25% and ROA of -7.9% indicating significant operational restructuring requirements. The EPS figure of -$13.14 reflects substantial losses that differentiate CNC from established peers like UNH, ELV, and HUM, which typically maintain positive earnings. The model indicates that sustained revenue growth without corresponding margin improvement creates an asymmetric fundamental profile within the managed care space.